The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs
Hasnat Ahmad, Julie A Campbell, Ingrid van der Mei, Bruce V Taylor, Ting Zhao, Andrew J Palmer
Multiple Sclerosis and Related Disorders | ELSEVIER SCI LTD | Published : 2020
BACKGROUND: Economic costs of Multiple Sclerosis (MS) in Australia were last estimated in 2010 and are likely to have changed over time, especially given this new era of increased access to higher efficacy disease modifying therapies (DMTs) with a strong focus on earlier MS diagnosis and treatment. OBJECTIVES: To provide a comprehensive contemporary analysis of the updated direct and indirect costs of MS in Australia from a societal perspective and to examine how the cost landscape has changed overtime. METHODS: Costs were estimated from the 2016 Economic Impact Survey (EIS) of the Australian MS longitudinal Study (AMSLS) and were stratified by various (indirect and direct) cost categories/s..View full abstract
This study was supported by an unconditional grant provided to MS Research Australia by Merck Australia.